Premium
Oestrogen receptor–co‐factor–chromatin specificity in the transcriptional regulation of breast cancer
Author(s) -
Zwart Wilbert,
Theodorou Vasiliki,
Kok Marleen,
Canisius Sander,
Linn Sabine,
Carroll Jason S
Publication year - 2011
Publication title -
the embo journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.484
H-Index - 392
eISSN - 1460-2075
pISSN - 0261-4189
DOI - 10.1038/emboj.2011.368
Subject(s) - biology , chromatin , breast cancer , transcription factor , cancer research , oestrogen receptor , genetics , progesterone receptor , cancer , estrogen receptor , medicine , gene
The complexity of oestrogen receptor α (ERα)‐mediated transcription is becoming apparent, but global insight into the co‐regulatory proteins that assist ERα transcription is incomplete. Here, we present the most comprehensive chromatin‐binding landscape of ERα co‐regulatory proteins to date. We map by ChIP‐seq the essential p160 co‐regulators (SRC1, SRC2 and SRC3), and the histone acetyl transferases p300 and CBP in MCF‐7 breast cancer cells. We find a complex network of co‐regulator binding, with preferential binding sites for each co‐regulator. Unlike previous suggestions, we find SRC recruitment almost exclusively following ligand treatment. Interestingly, we find specific subsets of genes regulated by ligand‐dependent and ‐independent co‐regulator recruitment. Co‐factor‐binding profiles were integrated with expression data from cell lines and primary tumour cohorts, to reveal specific transcriptional networks that influence clinical outcome. Genes that are bound by SRC3, but not other p160 proteins, have predictive value in cohorts of breast cancer patients. By generating a robust and global view of co‐factor‐binding properties, we discover new levels of co‐regulator complexity, but also reveal specific gene networks that may influence endocrine response.